Molecular Diagnostics Market to exceed US$ 20 Billion by 2024
- 6 years ago
For more Info:
https://www.renub.com/molecular-diagnostics-market-nd.php
Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.
Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)
Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.
Request a free sample copy of the report:
https://www.renub.com/contactus.php
Molecular Diagnostics for Infectious Disease
Over the last several years, the expansion and application of molecular diagnostic techniques has spurred a revolution in the field of disease diagnosis and monitoring, especially for infectious diseases. Microbial phenotypic characteristics, such as bacteriophage, protein and chromatographic profiles, as well as susceptibility testing and biotyping, are used wide openly in today’s everyday laboratories for identification and differentiation. Nucleic acid techniques, such as various methods for generating restriction fragment length polymorphisms, plasmid profiling, and the polymerase chain reaction (PCR), are making increasing incursion into clinical laboratories. A PCR-based system helps to detect the etiology of the disease straight from the clinical samples without the need for culture and have been significantly useful in the rapid detection of un-culturable or fastidious microbes. In addition; sequence analysis of amplified microbial DNA allows for better characterization and identification of the pathogen.
https://www.renub.com/molecular-diagnostics-market-nd.php
Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.
Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)
Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.
Request a free sample copy of the report:
https://www.renub.com/contactus.php
Molecular Diagnostics for Infectious Disease
Over the last several years, the expansion and application of molecular diagnostic techniques has spurred a revolution in the field of disease diagnosis and monitoring, especially for infectious diseases. Microbial phenotypic characteristics, such as bacteriophage, protein and chromatographic profiles, as well as susceptibility testing and biotyping, are used wide openly in today’s everyday laboratories for identification and differentiation. Nucleic acid techniques, such as various methods for generating restriction fragment length polymorphisms, plasmid profiling, and the polymerase chain reaction (PCR), are making increasing incursion into clinical laboratories. A PCR-based system helps to detect the etiology of the disease straight from the clinical samples without the need for culture and have been significantly useful in the rapid detection of un-culturable or fastidious microbes. In addition; sequence analysis of amplified microbial DNA allows for better characterization and identification of the pathogen.